Public Employees Retirement System of Ohio held its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the first quarter, Holdings Channel reports. The fund owned 405,603 shares of the medical research company’s stock at the end of the first quarter. Public Employees Retirement System of Ohio’s holdings in Thermo Fisher Scientific were worth $62,301,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Stonebridge Capital Advisors LLC increased its stake in shares of Thermo Fisher Scientific by 3.7% in the first quarter. Stonebridge Capital Advisors LLC now owns 37,969 shares of the medical research company’s stock worth $5,832,000 after buying an additional 1,338 shares in the last quarter. Teachers Retirement System of The State of Kentucky increased its stake in shares of Thermo Fisher Scientific by 0.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 90,199 shares of the medical research company’s stock worth $13,855,000 after buying an additional 459 shares in the last quarter. Achmea Investment Management B.V. purchased a new stake in shares of Thermo Fisher Scientific during the first quarter worth approximately $2,559,000. North Star Asset Management Inc. increased its stake in shares of Thermo Fisher Scientific by 4.1% in the first quarter. North Star Asset Management Inc. now owns 48,571 shares of the medical research company’s stock worth $7,461,000 after buying an additional 1,932 shares in the last quarter. Finally, Bank of Nova Scotia increased its stake in shares of Thermo Fisher Scientific by 50.7% in the first quarter. Bank of Nova Scotia now owns 239,394 shares of the medical research company’s stock worth $36,771,000 after buying an additional 80,519 shares in the last quarter. 87.60% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded up 0.35% during trading on Tuesday, hitting $174.64. 353,874 shares of the stock were exchanged. The stock has a market cap of $68.13 billion, a P/E ratio of 30.43 and a beta of 1.06. The stock has a 50-day moving average of $176.77 and a 200 day moving average of $166.03. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.03 earnings per share. Equities analysts predict that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.34%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.watchlistnews.com/public-employees-retirement-system-of-ohio-maintains-position-in-thermo-fisher-scientific-inc-tmo/1491840.html.

A number of equities research analysts have commented on the stock. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $197.00 price objective on the stock in a research report on Tuesday, August 1st. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation reissued a “buy” rating and issued a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, Barclays PLC reaffirmed an “overweight” rating and issued a $200.00 target price (up from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. One investment analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $188.56.

In related news, CFO Stephen Williamson sold 2,500 shares of the company’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $176.26, for a total value of $440,650.00. Following the completion of the sale, the chief financial officer now owns 37,790 shares of the company’s stock, valued at $6,660,865.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Marc N. Casper sold 20,000 shares of the company’s stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the completion of the sale, the chief executive officer now directly owns 269,279 shares of the company’s stock, valued at approximately $46,528,718.41. The disclosure for this sale can be found here. Insiders sold 27,188 shares of company stock valued at $4,702,223 in the last ninety days. Corporate insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.